FindTrial
Sign In

Propranolol for Treatment of Cocaine Addiction - 2

Propranolol for Treatment of Cocaine Addiction

Status
Completed
Phases
Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00000197
Enrollment
0
Registered
1999-09-21
Start date
1987-01-31
Completion date
2002-01-31
Last updated
2017-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cocaine-Related Disorders

Keywords

cocaine

Brief summary

The purpose of this study is to evaluate the safety and efficacy of propanolol in the early treatment of cocaine dependence.

Interventions

DRUGPropranolol

Sponsors

University of Pennsylvania
CollaboratorOTHER
National Institute on Drug Abuse (NIDA)
Lead SponsorNIH

Study design

Primary purpose
TREATMENT

Eligibility

Sex/Gender
ALL
Age
25 Years to 49 Years
Healthy volunteers
No

Inclusion criteria

Please contact site for information.

Design outcomes

Primary

MeasureTime frame
Side effects—
Cocaine use—
Cocaine withdrawal—
Cocaine craving—
Mood and anxiety—
Clinical improvement—

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026